Antiepileptic drugs as objects of the national pharmaceutical market. Message 1. Characteristics of the nomenclature of antiepileptic drugs from the point of view of the state guarantee program of medical care of the population

Authors

  • Pavlo Henyk Danylo Halytsky Lviv National Medical University, Lviv, Ukraine, Ukraine
  • Oxana Levitska Lviv National Medical University named after Daniil Galitsky, Lviv, Ukraine
  • Iryna Chukhraу Danylo Halytsky Lviv National Medical University, Lviv, Ukraine, Ukraine
  • Natalia Jarko Danylo Halytsky Lviv National Medical University, Lviv, Ukraine, Ukraine
  • Sophya Tereshchuk Andrey Krupynskyi Lviv Medical Academy, Lviv, Ukraine , Ukraine
  • Bohdan Hromovyk Danylo Halytsky Lviv National Medical University, Lviv, Ukraine, Ukraine

DOI:

https://doi.org/10.5281/zenodo.10256357

Abstract

Introduction. Epilepsy, as a chronic non-infectious disease of the brain, affects according to some data about 50 million, according to others - about 65 million people worldwide. Epilepsy can be treated with antiepileptic drugs (AEDs), diet therapy, and surgery. AEDs are drugs of various origin, which are used to prevent or reduce (in intensity and frequency) seizures, their corresponding equivalents (loss or disturbance of consciousness, behavioral and autonomic disorders, etc.), which are observed during periodically occurring attacks of various forms of epilepsy. The peculiarity of the treatment of epilepsy is the need for regular daily intake of AEDs for many years, including at least 3-5 years after the cessation of seizures. The number of patients forced to take AEDs during whole life reaches 15%. Material & methods. The sources of information were: domestic and foreign web resources, the State Register of Medicines of Ukraine (for searching of AEDs) (as of February 1, 2023), registers of drugs which are subjects to reimbursement under the medical guarantee program. The several methods were used in the research, such as: information search, comparison, analysis, generalization, marketing.  Results & discussion. The analytical study of AEDs showed that in Ukraine as of February 1, 2023, were registered 325 trade names (TN) of AEDs, which represented 16 international non-propriatory names (INN). About half (48.85%) of the researched assortment is made by pregabalin-based medicines. Almost one-eighth parts of the assortment (12.92% each) is taken by lamotrigine and levitiracetam TN. In total, drugs of these three INNs make up about 72% of the nomenclature of AEDs. The distribution of the studied assortment by dosage forms type showed that the absolute majority of AEDs was represented by capsules (51.08%) and tablets (45.23%).  It was established that three-quarters (75.38%) of the nomenclature of AEDs are drugs of foreign production. They are represented by 65 companies from 23 countries of the world. Among them, the vast majority (88.57%) are produced by one company, a tenth part (10.20 %) – by two-three manufacturers, and three TN of Pregabalin euro (1.22 %) – by 13 enterprises. As for domestic medicines, they are represented by 13 manufacturers, and 9 out of 10 (93.75%) of their products are made by one, and the rest by two companies. High production activity regarding AEDs is characteristic of enterprises from India (16.67% of manufacturers, Index of Production Activity (IPA) = 26.28%) and Ukraine (16.67% of manufacturers, IPA = 22.96%). Among foreign enterprises, the highest production activity has Dr. Reddy's Laboratories Limited, India (IPA = 6.63%), and among Ukrainian manufacturers - LLC "Pharma Start" (IPA = 3.83%). As a result of the data analysis of 5 Registers of medicines, the prices of which are subject to reimbursement under the program of state guarantee program of medical care of the population for 2021-2023, an increase in the number of AEDs INN from 3 to 4 was found. The analysis of the latest Register as of August 10, 2023 showed that it included 31 TN of these drugs (lamotrigine – 18, carbamazepine – 10, valproic acid – 2 and phenytoin – 1). At the same time, patients with epilepsy can receive 10 medicines free of charge, with a surcharge of up to 10% of the cost - 1 medicine, with a surcharge of 10-20% - 4 medicines, 21-30% - 10 medicines, 31-40% - 2 medicines, and in within 41-50% - 4 medicines. Conclusion.  Separate components of the marketing complex regarding antiepileptic drugs registered in Ukraine and their role in the context of the program of state guarantee program of medical care of the population were studied.

Keywords: Еpilepsy, antiepileptic drugs, reimbursement, Index of Production Activity

References

Zack M. M., Kobau R. National and state estimates of the numbers of adults and children with active epilepsy – United States, 2015. MMWR, 2017. 66 (31). P. 821-825. doi: 10.15585/mmwr.mm6631a1.

England M. J., Liverman C. T., Schultz A. M. et al. Epilepsy Across the Spectrum: Promoting Health and Understanding. Washington, DC: National Academies Press (US); 2012. PMID: 22993876.

Epilepsy – World Health Organization (WHO), 2022. URL: https://www.who.int/news-room/fact-sheets/detail/epilepsy.

Epilepsy statistics 2022. SingleCare, 2022. URL: https://www.singlecare.com/blog/news/epilepsy-statistics/.

Kanner A. M., Bicchi M. M. Antiseizure Medications for Adults With Epilepsy: A Review. JAMA, 2022. 327 (13). P. 1269–1281. doi:10.1001/jama.2022.3880 URL: https://jamanetwork.com/journals/jama/article-abstract/2790629.

What you need to know about epilepsy. Center for public health. URL: https://www.phc.org.ua/news/scho-treba-znati-pro-epilepsi.

Global Actions on epilepsy and other neurological disorders. WHO. Seventy-third World Health Assembly. A73/A/CONF./2 Agenda item 11.6 9 November 2020. URL: https://apps.who.int/gb/ebwha/pdf_files/WHA73/A73_ACONF2-en.pdf.

Epilepsy. Treatments. American Association of Neurological Surgeons. URL: https://www.aans.org/en/Patients/Neurosurgical-Conditions-and-Treatments/Epilepsy

Pharmacology: textbook for students of medical faculties / Chekman I.S., Horchakova N.O., Kazak L.I. [et al.] ; under the editorship of Prof. I. S. Chekman. 3rd edition. Vinnytsya: Nova Knyha, 2016. 784 p.

Bazil C. W., Morrell M. J., Pedley T. A. Epilepsy. In: Rowland L.P., editor. Merritt’s Neurology. 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. P. 990–1008.

Bui A., Kim H., Moroso M., Soltesz I. Microcircuits in epilepsy: Heterogeneity and hub cells in network synchronization. Cold Spring Harb Perspect Med. 2015.10.1101/cshperspect.a022855.

Stafstrom C. E., Carmant L. Seizures and epilepsy: an overview for neuroscientists. Cold Spring Harb Perspect Med. 2015. 5(6):a022426. doi: 10.1101/cshperspect.a022 URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448698/.

Goldenberg M. M. Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment. Pharmacy and Therapeutics. 2010. 35(7). P. 392-415. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912003/.

Horachuk V.V. Medico-social and economic aspects of epilepsy. Ukrainian medical journal. 2011. 5 (85) ІХ-Х. P. 42-44.

On the approval and implementation of medical and technological documents on the standardization of medical care for epilepsy: Order of the Ministry of Health of Ukraine dated 17.04.2014 No 276. URL: https://zakon.rada.gov.ua/rada/show/v0276282-14#Text.

The use of antiepileptic drugs for the treatment of epilepsy in Ukraine according to the data of the electronic register. A.Ye. Dubenko, S.O. Sazonov, Yu.A. Babkina et al. NeuroNEWS: neurology and psychiatry. 2018. 1. P.10-14. URL: https://neuronews.com.ua/uploads/issues/2018/1/nn18spec-1_10-14_f452e2ef4ae770a38f4903389021f5db.pdf.

Gryn’kiv Ya.O., Zelenyuk O.K., Zavada L.O., Mandyuk O.O, Parnovskyy B.L. Integration of medical and pharmaceutical care for epileptic patients. Management, economy and quality assurance in pharmacy. 2011. 5 (19). P. 44-47.

Gryn’kiv Ya.O. Study of information need of pharmacy workers on antiepileptic drugs. Management, economy and quality assurance in pharmacy. 2011. 6 (20). P. 60 – 65.

Prуlуpko N.A., Grynkiv Ya.O. Antiepileptic drugs: interaction, specificity of application. Pharmaceutical Journal. 2017. 3-4. P. 26-33.

Danylchenko A.O., Nimenko H.R. Definition of the Ukrainian drug market from the group of antiepileptic drugs. Current issues of modern medicine and pharmacy: coll. of theses at science and practice conf. with the international participation of young scientists and students, 13–17 may 2019, Zaporizhzhya: ZSMU, 2019. P. 139-140.

Compendium OnLine. URL: http:// compendium.com.ua/uk/.

State register of medicines of Ukraine. URL: http://www.drlz.com.ua/.

On the approval of the Register of medicines that are subject to reimbursement under the state guarantee program of medical care of the population, as of October 1, 2021. Order of the Ministry of Health of Ukraine dated 27.09.2021 No 2077. URL: https://www.apteka.ua/article/611429.

On the approval of the Register of medicines that are subject to reimbursement under the state guarantee program of medical care of the population, as of February 18, 2022. Order of the Ministry of Health of Ukraine dated 25.02.2022 No 366. URL: https://www.apteka.ua/article/630031.

On the approval of the Register of medicines that are subject to reimbursement under the state guarantee program of medical care of the population, as of October 20, 2022. Order of the Ministry of Health of Ukraine dated 27.10.2022 No 1931. URL: https://zakon.rada.gov.ua/rada/show/v1931282-22#Text.

On the approval of the Register of medicines that are subject to reimbursement under the state guarantee program of medical care of the population, as of February 14, 2023. Order of the Ministry of Health of Ukraine dated 01.02.2023 No 351. URL: https://zakon.rada.gov.ua/rada/show/v0351282-23#Text.

On the approval of the Lists of medicines and medical devices, which are the subjects to reimbursement under the state guarantee program of medical care of the population, as of August 10, 2023. Order of the Ministry of Health of Ukraine dated 21.08.2023 No 1495. URL: https://zakon.rada.gov.ua/rada/show/v1495282-23#Text.

Published

2023-12-06

How to Cite

Henyk, P., Levitska, O., Chukhraу I., Jarko, N., Tereshchuk, S., & Hromovyk, B. (2023). Antiepileptic drugs as objects of the national pharmaceutical market. Message 1. Characteristics of the nomenclature of antiepileptic drugs from the point of view of the state guarantee program of medical care of the population. Annals of Mechnikov’s Institute, (4), 90–98. https://doi.org/10.5281/zenodo.10256357

Issue

Section

Research Articles